Genetic factors predicting IFN-gamma generation potential in patients with sarcoidosis and after haematopoietic stem cell transplantation

International Journal of Immunogenetics

Volumn 35, Issue 4-5, 2008, Pages 385-388

  Lange, A ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b Lower Silesian Centre for Cellular Transplantation   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; GAMMA INTERFERON; HLA B8 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ALLELE; ARTICLE; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; DISEASE COURSE; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HOMOZYGOTE; HUMAN; IMMUNE RESPONSE; LOFGREN SYNDROME; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RISK FACTOR; SARCOIDOSIS; VIRUS REACTIVATION;

ANIMALS; CYTOKINES; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERFERON-GAMMA; SARCOIDOSIS; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 4;

EID: 52649134946     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2008.00796.x     Document Type: Article

References (32)

1. Abraham, L.J., French, M.A. Dawkins, R.L. (1993) Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clinical and Experimental Immunology, 92, 14.
2. Allione, A., Bernabei, P., Bosticardo, M., Ariotti, S., Forni, G. Novelli, F. (1999) Nitric oxide suppresses human t lymphocyte proliferation through IFN-{gamma}-dependent and IFN-{gamma}-independent induction of apoptosis. Journal of Immunology, 163, 4182.
3. Bogunia-Kubik, K., Mlynarczewska, A., Jaskula, E. Lange, A. (2006) The presence of IFNG 3/3 genotype in the recipient associates with increased risk for Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation. British Journal of Haematology, 132, 326.
4. Bogunia-Kubik, K., Mlynarczewska, A., Wysoczanska, B. Lange, A. (2005) Recipient IFN-gamma 3/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Haematologica, 90, 425.
5. Candore, G., Romano, G.C., D'Anna, C., Di Lorenzo, G., Gervasi, F., Lio, D., Modica, M.A., Potestio, M. Caruso, C. (1998) Biological basis of the HLA-B8,DR3-associated progression of acquired immune deficiency syndrome. Pathobiology, 66, 33.
6. Cavet, J., Dickinson, A.M., Norden, J., Taylor, P.R., Jackson, G.H. Middleton, P.G. (2001) Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood, 98, 1594.
7. Degli-Esposti, M.A., Andreas, A., Christiansen, F.T., Schalke, B., Albert, E. Dawkins, R.L. (1992) An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes. Immunogenetics, 35, 355.
8. Dickinson, A.M. Charron, D. (2005) Non-HLA immunogenetics in hematopoietic stem cell transplantation. Current Opinion in Immunology, 17, 517.
9. Gouwy, M., Struyf, S., Proost, P. Van Damme, J. (2005) Synergy in cytokine and chemokine networks amplifies the inflammatory response. Cytokine Growth Factor Review, 16, 561.
10. Haddad, J.J. (2002) Cytokines and related receptor-mediated signaling pathways. Biochemical and Biophysical Research Communications, 297, 700.
11. Hashimoto, S., McCombs, C.C. Michalski, J.P. (1989) Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals. Clinical and Experimental Immunology, 76, 317.
12. Karabon, L., Wysoczanska, B., Bogunia-Kubik, K., Suchnicki, K. Lange, A. (1996) Serum interferon-gamma and C-reactive protein levels as predictors of acute graft-vs.-host disease in allogeneic hematopoietic precursor cell (marrow or peripheral blood progenitor cells) recipients. Transplantation Proceedings, 28, 3522.
13. Lange, A., Caba, C., Garncarek-Lange, D., Tomeczko, J., Matej, H. Nowakowska, B. (1989) Risk factors of asbestos-related cancers. W. In: Effects of Mineral Dusts on Cells. NATO ASI Series (Ed. B.T. Mossman R.O Begin H30, p. 445. Springer-Verlag, New York.
14. Lange, A., Skibinski, G. Garncarek, D. (1980) The follow-up study of skin reactivity to recall antigens and E- and EAC-RFC profiles in blood in asbestos workers. Immunobiology, 157, 1.
15. Lee, T.C., Savoldo, B., Barshes, N.R., Rooney, C.M., Heslop, H.E., Gee, A.P., Caldwell, Y., Scott, J.D. Goss, J.A. (2006) Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Clinical Transplantation, 20, 389.
16. Martino, G., Moiola, L., Brambilla, E., Clementi, E., Comi, G. Grimaldi, L.M.E. (1995) Interferon-gamma induces T lymphocyte proliferation in multiple sclerosis via a Ca2+-dependent mechanism. Journal of Neuroimmunology, 62, 169.
17. Matej, H., Lange, A., Garncarek, D., Smolik, R. Roszak, E. (1978) HLA and antinuclear antibody incidence in asbestos workers. Archivum Immunologiae et Therapiae Experimentalis, 26, 201.
18. McDevitt, H.O. (2000) Discovering the role of the major histocompatibility complex in the immune response. Annual Review of Immunology, 18, 1.
19. Mlynarczewska, A., Wysoczanska, B., Karabon, L., Bogunia-Kubik, K. Lange, A. (2004) Lack of IFN-gamma 2/2 homozygous genotype independently of recipient age and intensity of conditioning regimen influences the risk of aGvHD manifestation after HLA-matched sibling haematopoietic stem cell transplantation. Bone Marrow Transplantation, 34, 339.
20. Modica, M.A., Cammarata, G. Caruso, C. (1990) HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin. Journal of Immunogenetics, 17, 101.
21. Murphy, W.J., Welniak, L.A., Taub, D.D., Wiltrout, R.H., Taylor, P.A., Vallera, D.A. et al 1998) Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. Journal of Clinical Investigation, 102, 1742.
22. Pravica, V., Asderakis, A., Perrey, C., Hajer, A., Sinnott, P.J. Hutchinson, I.V. (1999) In vitro production of interferon-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. European Journal of Immunogenetics, 26, 1.
23. Pravica, V., Perrey, C., Stevens, A., Lee, J.H. Hutchinson, I.V. (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Human Immunology, 61, 863.
24. Seitzer, U., Swider, C., Stuber, F., Suchnicki, K., Lange, A., Richter, E. et al 1997) Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine, 9, 787.
25. Swider, C., Schnittger, L., Bogunia-Kubik, K., Gerdes, J., Flad, H., Lange, A. Seitzer, U. (1999) TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. European Cytokine Network, 10, 143.
26. Wilson, A.G., de Vries, N., Pociot, F., di Giovine, F.S., van der Putte, L.B., Duff, G. W. (1993) An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. Journal of Experimental Medicine, 177, 557.
27. Wilson, A.G., di Giovine, F.S., Blakemore, A.I. Duff, G.W. (1992) Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Human Molecular Genetics, 1, 353.
28. Wysoczanska, B., Bogunia-Kubik, K., Suchnicki, K., Mlynarczewska, A. Lange, A. (2004) Combined association between IFN-gamma 3,3 homozygosity and DRB1*03 in Lofgren's syndrome patients. Immunology Letter, 91, 127.
29. Yadav, D. Sarvetnick, N. (2003) Cytokines and autoimmunity: redundancy defines their complex nature. Current Opinion in Immunology, 15, 697.
30. Yang, Y.G., Dey, B., Sergio, J.J., Pearson, D.A. Sykes, M. (1998) Donor-derived interferon γ is required for inhibition of acute graft-versus-host disease by interleukin 12. Journal of Clinical Investigation. 102, 2126.
31. Yang, Y.G., Wang, H., Asavaroengchai, W. Dey, B.R. (2005) Role of Interferon-gamma in GVHD and GVL. Cellular and Molecular Immunology, 2, 323.
32. Yu, H., Zhu, Q.R., Gu, S.Q. Fei, L.E. (2006) Relationship between IFN-gamma gene polymorphism and susceptibility to intrauterine HBV infection. World Journal of Gastroenterology, 12, 2928.